The Royal Cornwall Hospital, formerly and still commonly known as the Treliske Hospital, is a medium-sized teaching hospital in Treliske, on the outskirts of Truro, Cornwall, England. The hospital provides training services for the University of Exeter Medical School.

There are 760 beds in Royal Cornwall Hospital.

During the past decade, Royal Cornwall Hospital conducted 137 clinical trials. In the 10-year time frame, 137 clinical trials started and 35 clinical trials were completed, i.e. on average, 25.5% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 28 clinical trials were completed. i.e. 43.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Cornwall Hospital" #1 sponsor was "Hoffmann-La Roche" with 20 trials, followed by "University College, London" with 13 trials sponsored, "Institute of Cancer Research, United Kingdom" with 9 trials sponsored, "Royal Cornwall Hospitals Trust" with 9 trials sponsored and "Eli Lilly and Company" with 9 trials sponsored. Other sponsors include 135 different institutions and companies that sponsored additional 96 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Cornwall Hospital" #1 collaborator was "Cancer Research UK" with 12 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Hoffmann-La Roche" with 5 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 5 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 120 different institutions and companies that were collaborators in the rest 111 trials.

According to Clinical.Site data, the most researched conditions in "Royal Cornwall Hospital" are "Breast Cancer" (19 trials), "Ovarian Cancer" (8 trials), "Lymphoma" (6 trials), "Metastatic Breast Cancer" (5 trials) and "Breast Neoplasms" (4 trials). Many other conditions were trialed in "Royal Cornwall Hospital" in a lesser frequency.

Most popular intervention types in "Royal Cornwall Hospital" are "Drug" (131 trials), "Other" (24 trials), "Procedure" (23 trials), "Biological" (22 trials) and "Device" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Atezolizumab" (9 trials), "Rituximab" (9 trials), "Carboplatin" (8 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Royal Cornwall Hospital" are 158 trials for "All" genders, 30 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Cornwall Hospital". 1 are not yet recruiting, 39 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 87 completed trials in Royal Cornwall Hospital, 2 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Cornwall Hospital, 7 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 22 trials that are defined as “Not Applicable".

Royal Cornwall Hospital has several departments that took part in Clinical trials: "Royal Cornwall Hospital; Dept of Clinical Oncology" - 12 trials, "Royal Cornwall Hospital; Haematology Clinic" - 2 trials, "Royal Cornwall Hospital; Rhuematololgy Dept" - 2 trials, "Department of Radiology" - 2 trials, "Royal Cornwall Hospital Truro Sunrise Centre" - 2 trials, "Pharmacy Department" - 2 trials